| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
| November 2015 Volume 11 Number 11 | |||||||||||||||||||||||||||||||||||||
In this issue
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| EDITORIAL | Top | ||||||||||||||||||||||||||||||||||||
Claire Greenhill Published online: 20 October 2015 p627 | doi:10.1038/nrendo.2015.170 Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| NEWS AND VIEWS | Top | ||||||||||||||||||||||||||||||||||||
Ian R. Reid Published online: 25 August 2015 p633 | doi:10.1038/nrendo.2015.143 Our understanding of bone biology and the subsequent development of therapies to treat bone diseases have both expanded greatly in the past 30 years. This article reviews some of the key advances made in these fields during the past decade. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
P. Reed Larsen Published online: 06 October 2015 p634 | doi:10.1038/nrendo.2015.169 The past decade has seen exciting progress in the field of thyroid disease, especially in the evaluation of thyroid nodules, the genomic characterization of carcinomas and the treatment of carcinomas after surgery. An improved understanding of hyperthyroidism during pregnancy, as well as the causes of 'low T3 syndrome' and consumptive hypothyroidism have also been achieved. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Guang Ning Published online: 25 August 2015 p636 | doi:10.1038/nrendo.2015.147 Over the past decade, the growing epidemic of type 2 diabetes mellitus (T2DM) and its associated complications has presented both challenges and opportunities. Progress has been made in incretin-based therapies, bariatric surgeries and inhibiting renal glucose reabsorption; however, long-term safety and efficacy studies are required. Advances in the prevention of macrovascular complications of T2DM from ongoing clinical trials are expected soon. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Mehul T. Dattani Published online: 08 September 2015 p638 | doi:10.1038/nrendo.2015.154 The past 10 years have seen substantial advances in many areas of paediatric endocrinology. Major progress has been made in our understanding of the aetiology of many disorders with the advent of next-generation sequencing. Furthermore, the introduction of novel therapies has revolutionized clinical management. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Ursula B. Kaiser Published online: 13 October 2015 p640 | doi:10.1038/nrendo.2015.179 The past decade has witnessed incredible advances in the field of reproductive endocrinology. The use of new genetic and genomic tools has had a particular impact, leading to advances in our understanding, diagnosis and treatment of reproductive endocrine disorders, particularly those related to the neuroendocrine control of reproduction and ovarian biology. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
| Scope and limitations of iodothyronine deiodinases in hypothyroidism Balázs Gereben, Elizabeth A. McAninch, Miriam O. Ribeiro & Antonio C. Bianco Published online: 29 September 2015 p642 | doi:10.1038/nrendo.2015.155 This Review outlines the physiologic role of the iodothyronine deiodinases, as well as the changes that occur in hypothyroidism, with a particular focus on their role in preserving thyroid hormone levels in the brain. Novel findings that underscore the clinical importance of iodothyronine deiodinases in hypothyroidism are also discussed. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Endocrine disruptors and obesity Jerrold J. Heindel, Retha Newbold & Thaddeus T. Schug Published online: 22 September 2015 p653 | doi:10.1038/nrendo.2015.163 A subclass of endocrine-disrupting chemicals, so-called 'obesogens', have been proposed to predispose certain individuals to weight gain, despite their efforts to limit caloric intake and increase levels of physical activity. In this Review, Jerrold Heindel and colleagues discuss the experimental and epidemiological findings on obesogens, their modes of action, and their role in the obesity epidemic. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Paget's disease of bone—genetic and environmental factors Frederick R. Singer Published online: 18 August 2015 p662 | doi:10.1038/nrendo.2015.138 Paget's disease is a disorder of bone that manifests in one or several bones and is initiated by osteoclast-induced osteolytic lesions. In addition to a genetic cause, environmental factors, including measles virus, have been proposed to have a role in the pathogenesis of Paget's disease. Here, Frederick R. Singer discusses the present knowledge and controversies surrounding the aetiology of Paget's disease. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| *Journal Citation Reports, Thomson, 2015. Nature Reviews Endocrinology was previously published as Nature Clinical Practice Endocrinology & Metabolism. |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment
Keep a civil tongue.